Chair/Chief Division of Medical Oncology

Ontario, Canada
Competitive salary and benefits
Jan 10, 2018
Feb 18, 2018
Medical Oncology
Full Time

Chair/Chief Division of Medical Oncology
London Regional Cancer Program

The London Regional Cancer Program (LRCP) of the London Health Sciences Centre (LHSC) is the primary academic regional cancer provider for Southwestern Ontario and provides a comprehensive range of cancer care services to a population of 1.5 million.  The Systemic Therapy Program provides high quality, innovative systemic therapy treatment services both at the LRCP and through Community Hospital Partners. Medical Oncology is a strong academic Division within the Department of Oncology, Schulich School of Medicine & Dentistry, Western University (in addition to Divisions of Radiation, Surgical and Experimental Oncology).  The Division supports active research programs in both Undergraduate and Postgraduate Medical Education with dedicated residency and fellowship training programs.  A Cancer Clinical Research Unit resides within the Baines Centre for Translational Cancer Research enables the conduct of Phase I-III clinical trials.  This unit also supports a unique program in both personalized medicine and pharmacogenomics research. 

The Division Chair/Chief provides clinical leadership to the Systemic Therapy Program and collaborates with Manager Clinic Services, Manager Pharmacy and Program Director in the organization of systemic therapy services.  In particular, the Division Chair/Chief is responsible for the provision of high quality, safe, patient centered care to cancer patients within the Systemic Therapy Program of the LRCP. Working with the Chair/Chief Department of Oncology, the Division Chair/Chief provides academic leadership to the Division to foster accountability for a strong academic portfolio including clinical research, participation in clinical trials, education, basic science and translational research. The Division Chair/Chief, in collaboration with the Medical Oncology Associates business group leads in the recruitment, mentoring and evaluation of clinical faculty within the Division.  

As the lead Cancer hospital in the region, LHSC is responsible for providing Medical Oncology consultation and treatment services to patients throughout Southwestern Ontario through a network of shared care satellite clinics located in five regional hospitals. The incumbent will work closely with the Regional Lead of the South West Regional Cancer Program of Cancer Care Ontario to ensure the smooth transition of patient care between the LRCP and community sites.

The successful candidate will have a track record of successful leadership within interdisciplinary environments and possess excellent interpersonal and communication skills.   The ability to manage competing demands in a fast paced environment, a commitment to quality patient and family centred care and strong team building skills are other key competencies for the position.  

The successful candidate will have an MD and certification within the Royal College of Physicians and Surgeons (or equivalent) and be eligible for licensure within the province in Ontario and participation in the Provincial Oncology Alternative Funding Plan.  The successful candidate will be expected to maintain an active clinical practice in Medical Oncology (0.4-0.5FTE) with the remainder devoted to medical leadership (0.4-0.5FTE) and research/teaching (0.1FTE).

In order to be considered for this position, please submit a completed application form (, letter of interest, names of three references and curriculum vitae to:

Glenn Bauman, MD, FRCPC
Professor and Chair/Chief
Department of Oncology
London Regional Cancer Program
790 Commissioners Road East
London, ON N6A 4L6
519-685-8500 ext. 53177

Positions are subject to budget approval. Applicants should have fluent written and oral communication skills in English. The University invites applications from all qualified individuals. In accordance with Canadian Immigration requirements, priority will be given to Canadian citizens and permanent residents.